Sylvie Claeysen

Divergent Roles of mGlu2 and mGlu3 Receptors in Amyloid‐β Production and Cognitive Dysfunctions in Alzheimer's Disease

Pierre‐André Lafon, Mireille Elodie Tsitokana, Ugo Guy Alenda, Yen-Ling Lian et autres

fr, cn (code pays fourni par la source)

An efficient step-by-step approach to select pleiotropic drug candidates against Alzheimer's disease: The discovery of neocopride

Christophe Rochais, Cédric Lecoutey, Georgia Culley, Thomas Curel et autres

fr, us (code pays fourni par la source)

Combining β 2 -AR agonism with butyrylcholinesterase inhibition, a synergistic neuroprotective action against Alzheimer's disease

Alice Wang, Thomas Curel, Sylvie Claeysen, Valentin Travers-Lesage et autres

fr (code pays fourni par la source)

The PREVCOG study: longitudinal and multimodal biomarker analyses for secondary prevention of Alzheimer's disease and cognitive decline in French memory clinics

Germain U. Busto, Cédric Turpinat, Sophie Navucet, Emmanuelle Le Bars et autres

fr, Maroc (code pays fourni par la source)

The same but different: impact of animal facility sanitary status on a transgenic mouse model of Alzheimer’s disease

Caroline Ismeurt, Patrizia Giannoni, Florence Servant, Linda-Nora Mekki et autres

fr (code pays fourni par la source)

Author response for "A Sensitive and Versatile Cell-Based Assay Combines Luminescence and Trapping Approaches to Monitor Unconventional Protein Secretion"

Morgane Denus, Aurore Filaquier, William Fargues, Éloïse Néel et autres

A Sensitive and Versatile Cell‐Based Assay Combines Luminescence and Trapping Approaches to Monitor Unconventional Protein Secretion

Morgane Denus, Aurore Filaquier, William Fargues, Éloïse Néel et autres

fr, au, gb (code pays fourni par la source)

Evidence from a mouse model supports repurposing an anti-asthmatic drug, bambuterol, against Alzheimer’s disease by administration through an intranasal route

Anne‐Claire Groo, Thomas Curel, Aurélie Malzert‐Fréon, Line Séguy et autres

fr (code pays fourni par la source)

Advancing Alzheimer's disease pharmacotherapy: efficacy of glucocorticoid modulation with dazucorilant (CORT113176) in preclinical mouse models

Geoffrey Canet, Charleine Zussy, Mathieu Vitalis, Françoise Morin et autres

fr, ca, us, nl (code pays fourni par la source)

Synthesis, in vitro and in vivo biological evaluation of novel dual compounds targeting both acetylcholinesterase and serotonergic 5-HT4 receptors with potential interest in the treatment of Alzheimer's disease

Christophe Rochais, Cédric Lecoutey, Julien Lalut, Audrey Davis et autres

fr (code pays fourni par la source)

International union of basic and clinical pharmacology. Cx. Classification of receptors for 5-hydroxytryptamine; pharmacology and function

Luc Maroteaux, Daniël Hoyer, Fone K.C, Katharine Herrick‐Davis et autres

us (code pays fourni par la source)

Chronic potentiation of metabotropic glutamate receptor 2 with a nanobody accelerates amyloidogenesis in Alzheimer’s disease

Pierre‐André Lafon, Mireille Elodie Tsitokana, Ugo G Alenda, Clementine Philibert et autres

fr, cn (code pays fourni par la source)